GlassScriptPhysician profile
Elizabeth Ping
NPI 1275278905
$909.20
in general payments reported to CMS, 2019-2025
12 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $169 · 2024: $278 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $909.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $270.95 | 2023-2024 | Krystexxa, Repatha |
| Abbvie INC. | $138.97 | 2024-2025 | |
| Pulmonx Corporation | $131.22 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Novo Nordisk INC | $121.19 | 2025 | Wegovy |
| Hologic Sales and Service, LLC | $105.52 | 2025 | Aptima |
| Janssen Biotech, INC. | $24.61 | 2025 | Tremfya |
| Ironshore Pharmaceuticals INC. | $23.85 | 2023 | Jornay Pm |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.69 | 2025 | Spevigo |
| Convatec INC. | $23.62 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.31 | 2025 | |
| Axsome Therapeutics, INC. | $15.92 | 2023 | Auvelity |
| Dynavax Technologies Corporation | $11.35 | 2024 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Ping listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.